| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative
|
Desai, Pinkal
|
|
2018
|
148 |
3 |
p. 540-546
|
artikel
|
| 2 |
Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register
|
Trabert, Britton
|
|
2018
|
148 |
3 |
p. 547-552
|
artikel
|
| 3 |
Bone loss in women with BRCA1 and BRCA2 mutations
|
Powell, C. Bethan
|
|
2018
|
148 |
3 |
p. 535-539
|
artikel
|
| 4 |
Cancer care delivery research in gynecologic oncology
|
Shalowitz, David I.
|
|
2018
|
148 |
3 |
p. 445-448
|
artikel
|
| 5 |
Cervical cancer – State of the science: From angiogenesis blockade to checkpoint inhibition
|
Minion, Lindsey E.
|
|
2018
|
148 |
3 |
p. 609-621
|
artikel
|
| 6 |
Defining and mitigating the challenges of an older and obese population in minimally invasive gynecologic cancer surgery
|
Hagemann, Andrea R.
|
|
2018
|
148 |
3 |
p. 601-608
|
artikel
|
| 7 |
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer
|
Kessous, Roy
|
|
2018
|
148 |
3 |
p. 553-558
|
artikel
|
| 8 |
Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer
|
Bacorro, Warren
|
|
2018
|
148 |
3 |
p. 461-467
|
artikel
|
| 9 |
Editorial Board
|
|
|
2018
|
148 |
3 |
p. ii
|
artikel
|
| 10 |
Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy
|
Stecklein, Shane R.
|
|
2018
|
148 |
3 |
p. 474-479
|
artikel
|
| 11 |
Expression and clinical role of long non-coding RNA in high-grade serous carcinoma
|
Filippov-Levy, Natalie
|
|
2018
|
148 |
3 |
p. 559-566
|
artikel
|
| 12 |
Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer
|
Tharavichitkul, Ekkasit
|
|
2018
|
148 |
3 |
p. 468-473
|
artikel
|
| 13 |
Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study
|
Soisson, Sean
|
|
2018
|
148 |
3 |
p. 499-506
|
artikel
|
| 14 |
Management of the toxicities of common targeted therapeutics for gynecologic cancers
|
Gunderson, Camille C.
|
|
2018
|
148 |
3 |
p. 591-600
|
artikel
|
| 15 |
Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers
|
Bergstrom, Jennifer
|
|
2018
|
148 |
3 |
p. 480-484
|
artikel
|
| 16 |
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target
|
Saed, Ghassan M.
|
|
2018
|
148 |
3 |
p. 567-575
|
artikel
|
| 17 |
Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis
|
Nitecki, Roni
|
|
2018
|
148 |
3 |
p. 521-526
|
artikel
|
| 18 |
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies
|
Gray, Heidi J.
|
|
2018
|
148 |
3 |
p. 507-514
|
artikel
|
| 19 |
Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices
|
Samimi, Goli
|
|
2018
|
148 |
3 |
p. 515-520
|
artikel
|
| 20 |
Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review
|
te Grootenhuis, Nienke C.
|
|
2018
|
148 |
3 |
p. 622-631
|
artikel
|
| 21 |
Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer
|
Harkenrider, Matthew M.
|
|
2018
|
148 |
3 |
p. 437-438
|
artikel
|
| 22 |
Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer
|
Park, Shin-Hyung
|
|
2018
|
148 |
3 |
p. 449-455
|
artikel
|
| 23 |
Racial disparities in young women with endometrial cancer
|
Mukerji, Barenya
|
|
2018
|
148 |
3 |
p. 527-534
|
artikel
|
| 24 |
Retroperitoneal lymphadenectomy for ovarian cancer with double inferior vena cava
|
Matsuoka, Ayumu
|
|
2018
|
148 |
3 |
p. 632-633
|
artikel
|
| 25 |
ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
|
Henry, C.E.
|
|
2018
|
148 |
3 |
p. 576-584
|
artikel
|
| 26 |
Sentinel lymph node biopsy in endometrial cancer—Feasibility, safety and lymphatic complications
|
Geppert, Barbara
|
|
2018
|
148 |
3 |
p. 491-498
|
artikel
|
| 27 |
SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm
|
Dostálek, L.
|
|
2018
|
148 |
3 |
p. 456-460
|
artikel
|
| 28 |
Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things
|
Dewdney, Summer B.
|
|
2018
|
148 |
3 |
p. 439-444
|
artikel
|
| 29 |
The NCI-MATCH trial and precision medicine in gynecologic cancers
|
Barroilhet, Lisa
|
|
2018
|
148 |
3 |
p. 585-590
|
artikel
|
| 30 |
The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia
|
Touhami, Omar
|
|
2018
|
148 |
3 |
p. 485-490
|
artikel
|
Tijdschrift beschrijving